Jess Jankowski - 10 Nov 2022 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (SLSN)

Reporting relationship: President, CEO, Director
Issuer ticker: SLSN
Reported as of: 10 Nov 2022
Net transaction value: -$25,631
SEC form: 4
Accepted by SEC: 14 Nov 2022, 18:00:24 UTC
Prior SEC filing: 09 Nov 2022
Next SEC filing: 17 Nov 2022
Source filing: View source filing
Reporting owner signature: Jess A. Jankowski

Key filing fact

Jess Jankowski filed Form 4 for NANOPHASE TECHNOLOGIES Corp (SLSN) on 14 Nov 2022.

Key facts

This page summarizes Jess Jankowski's Form 4 filing for NANOPHASE TECHNOLOGIES Corp (SLSN).
13 reported transactions and 11 derivative rows are listed below.
Accepted by SEC: 14 Nov 2022, 18:00.

Change

Previous filing in this sequence was filed on 09 Nov 2022.
Current net transaction value: -$25,631.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NANX transaction

Common Stock

Options Exercise

Transaction value: $83
Shares: +200
Change %: +0.34%
Price: $0.4150
Shares after: 59,200
Date: 10 Nov 2022
Ownership: Direct
Footnotes: F1

NANX transaction

Common Stock

Sale

Transaction value: $420
Shares: -200
Change %: -0.34%
Price: $2.10
Shares after: 59,000
Date: 10 Nov 2022
Ownership: Direct

NANX transaction

Common Stock

Options Exercise

Transaction value: $83
Shares: +200
Change %: +0.34%
Price: $0.4150
Shares after: 59,200
Date: 11 Nov 2022
Ownership: Direct
Footnotes: F1

NANX transaction

Common Stock

Sale

Transaction value: $394
Shares: -200
Change %: -0.34%
Price: $1.97
Shares after: 59,000
Date: 11 Nov 2022
Ownership: Direct

NANX transaction

Common Stock

Options Exercise

Transaction value: $581
Shares: +1,400
Change %: +2.4%
Price: $0.4150
Shares after: 60,400
Date: 11 Nov 2022
Ownership: Direct
Footnotes: F1

NANX transaction

Common Stock

Sale

Transaction value: $2,744
Shares: -1,400
Change %: -2.3%
Price: $1.96
Shares after: 59,000
Date: 11 Nov 2022
Ownership: Direct

NANX transaction

Common Stock

Options Exercise

Transaction value: $2,069
Shares: +4,986
Change %: +8.5%
Price: $0.4150^*
Shares after: 63,986
Date: 11 Nov 2012
Ownership: Direct
Footnotes: F1

NANX transaction

Common Stock

Sale

Transaction value: $9,723
Shares: -4,986
Change %: -7.8%
Price: $1.95
Shares after: 59,000
Date: 11 Nov 2022
Ownership: Direct

NANX transaction

Common Stock

Options Exercise

Transaction value: $2,698
Shares: +6,500
Change %: +11%
Price: $0.4150
Shares after: 65,500
Date: 14 Nov 2022
Ownership: Direct
Footnotes: F1

NANX transaction

Common Stock

Sale

Transaction value: $12,350
Shares: -6,500
Change %: -9.9%
Price: $1.90
Shares after: 59,000
Date: 14 Nov 2022
Ownership: Direct

NANX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 10 Nov 2022
Ownership: Spouse's IRA

NANX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 59,000
Date: 10 Nov 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NANX transaction Derivative

Common Stock (right to purchase)

Options Exercise

Transaction value: $83
Shares: -200
Change %: -0.29%
Price: $0.4150
Shares after: 69,017
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 69,217
Exercise price: $0.4150
Footnotes: F2

NANX transaction Derivative

Common Stock (right to purchase)

Options Exercise

Transaction value: $2,733
Shares: -6,586
Change %: -9.5%
Price: $0.4150
Shares after: 62,431
Date: 11 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 69,017
Exercise price: $0.4150
Footnotes: F2

NANX transaction Derivative

Common Stock (right to purchase)

Options Exercise

Transaction value: $2,698
Shares: -6,500
Change %: -10%
Price: $0.4150
Shares after: 55,931
Date: 14 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,431
Exercise price: $0.4150
Footnotes: F2

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 90,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.5200
Footnotes: F3

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 81,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 81,000
Exercise price: $0.4400
Footnotes: F4

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 69,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 69,000
Exercise price: $0.4200
Footnotes: F4

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 81,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 81,000
Exercise price: $0.6800
Footnotes: F4

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 90,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.8200
Footnotes: F5

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,500
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,500
Exercise price: $0.5100
Footnotes: F3

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 90,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.4500
Footnotes: F3

NANX holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 90,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $4.17
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.

Footnote F2

These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.

Footnote F3

Subject to certain restrictions, beginning on this date, options vest in three equal installments.

Footnote F4

Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.

Footnote F5

Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

SEC remarks

Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having shares from this grant sold, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. The maturity of these rights cannot be extended beyond the IRS statutory limit of ten years.